Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04343157 · ClinicalTrials.gov registry record · Phase 2
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases
A Phase 2 study of Cancer and Brain Metastases, Adult, sponsored by Jona Hattangadi-Gluth.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT04343157 is a Phase 2 study of Cancer and Brain Metastases, Adult that is actively recruiting participants, run by Jona Hattangadi-Gluth. The registered enrollment target is 60 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04343157, a Phase 2 study of Cancer and Brain Metastases, Adult, is actively recruiting participants, sponsored by Jona Hattangadi-Gluth.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
In this proposal, the investigators introduce advanced diffusion and volumetric imaging techniques along with innovative, automated image parcellation methods to identify critical brain regions, incorporate into cognitive-sparing SRS, and analyze biomarkers of radiation response. This work will advance the investigators' understanding of neurocognitive changes after brain SRS and help create interventions that preserve cognitive-function in brain metastases patients.
Conditions Studied
Interventions
- RADIATION Cognitive Sparing Brain Stereotactic Radiosurgery (SRS)
Study Locations (1)
California
- Moores Cancer Center - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2024-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04343157
The ClinicalTrials.gov registry entry for NCT04343157 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Jona Hattangadi-Gluth, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Sparing Brain Stereotactic Radiosurgery (SRS) is the first listed.
NCT04343157 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04343157 about?
NCT04343157 is a clinical study titled "UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases". In this proposal, the investigators introduce advanced diffusion and volumetric imaging techniques along with innovative, automated image parcellation methods to identify critical brain regions, incorporate into cognitive-sparing SRS, and analyze biomarkers of radiation response. This work will adva...
What is the current status of trial NCT04343157?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2019-05-01. Estimated completion is 2024-12-31.
What conditions does trial NCT04343157 study?
This clinical trial studies the following conditions: Cancer, Brain Metastases, Adult, Neurocognitive Function.
What interventions are being tested in trial NCT04343157?
The interventions under investigation include: Cognitive Sparing Brain Stereotactic Radiosurgery (SRS) (RADIATION).
Who is sponsoring clinical trial NCT04343157?
This trial is sponsored by Jona Hattangadi-Gluth, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04343157 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
RECRUITING · Phase 2
-
CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth
RECRUITING · Phase 2
-
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
RECRUITING · Phase 2
-
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
RECRUITING · Phase 2
-
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.